NSCLC (NON-SMALL CELL LUNG CARCINOMA)

Clinical trials for NSCLC (NON-SMALL CELL LUNG CARCINOMA) explained in plain language.

Never miss a new study

Get alerted when new NSCLC (NON-SMALL CELL LUNG CARCINOMA) trials appear

Sign up with your email to follow new studies for NSCLC (NON-SMALL CELL LUNG CARCINOMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1

New combo attack on Tough-to-Treat lung cancer

Disease control Not yet recruiting

This study is testing whether combining a targeted pill called firmonertinib with radiation therapy can help control stage III lung cancer that cannot be surgically removed and has specific, less common genetic changes. It aims to see if this approach can delay cancer growth and …

Matched conditions: NSCLC (NON-SMALL CELL LUNG CARCINOMA)

Phase: PHASE2 • Sponsor: Hunan Cancer Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

NSCLC (NON-SMALL CELL LUNG CARCINOMA)

Get alerted when new NSCLC (NON-SMALL CELL LUNG CARCINOMA) trials appear

New combo attack on Tough-to-Treat lung cancer